LP
LLY icon

LMR Partners’s Eli Lilly LLY Stock Holding History

LMR Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57,300
Closed -$52.7M – 1661
2026
Q1 		$52.7M Buy
57,300
+39,500
+222% +$40M 0.12% 94
2025
Q4 		$19.1M Buy
17,800
+14,800
+493% +$14.2M 0.04% 213
2025
Q3 		$2.29M Sell
3,000
-142,400
-98% -$106M 0.01% 694
2025
Q2 		$113M Buy
145,400
+85,800
+144% +$66.7M 0.81% 17
2025
Q1 		$49.2M Buy
59,600
+4,100
+7% +$3.41M 0.46% 38
2024
Q4 		$42.8M Buy
55,500
+10,500
+23% +$8.69M 0.36% 46
2024
Q3 		$39.9M Buy
+45,000
New +$40.5M 0.32% 56
2024
Q1 		– Sell
-11,700
Closed -$6.82M – 1244
2023
Q4 		$6.82M Sell
11,700
-28,200
-71% -$16.5M 0.08% 250
2023
Q3 		$21.4M Hold
39,900
– – 0.24% 103
2023
Q2 		$18.7M Buy
+39,900
New +$16.7M 0.21% 108

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LMR Partners's LLY Position: Q2 2026 in Review

LMR Partners reduced its Eli Lilly (LLY) stake by 96% in Q2 2026, selling an estimated $92.1M and leaving 3,390 shares worth $4.07M. The position accounts for 0.02% of the portfolio, ranked #712.

LMR Partners first reported a position in LLY in Q2 2015 and has held it in 24 quarters since. The position peaked at $86M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LMR Partners held 3,390 shares of Eli Lilly worth $4.07M as of Q2 2026.
  • LMR Partners sold 90,149 Eli Lilly shares in Q2 2026, an estimated $92.1M.
  • Eli Lilly made up 0.02% of LMR Partners's portfolio in Q2 2026, its #712 holding.
  • LMR Partners first reported a position in Eli Lilly in Q2 2015 and has held it in 24 quarters since.
  • LMR Partners's Eli Lilly position peaked at $86M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.